# A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients

> **NCT00077610** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 673 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Epoetin alfa or beta
- **DRUG:** RO0503821 (1x/2 Weeks)
- **DRUG:** RO0503821 (1x/4 Weeks)

## Key facts

- **NCT ID:** NCT00077610
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 673 (ACTUAL)
- **Last updated:** 2017-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00077610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00077610, "A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00077610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*